First US treatment with Medtronic's heart device:
This article was originally published in Clinica
Executive Summary
Cardiologists have successfully implanted Medtronic's InSync device for treating heart failure, the first implant of the device in the US. The device, designed to synchronise the beating of the right and left side of the of the heart, as well as the upper and lower chambers, uses three transvenous leads to stimulate three chambers of the heart. Stimulation of the left ventricle is achieved via a lead passed through a coronary vein on the surface of the heart and therefore avoids open chest surgery. The InSync device is already available in Europe, said Minneapolis-based Medtronic.
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.